Many pathology practices bill CPT 88305 every single day and still leave thousands of dollars on the table every month. Wrong modifiers, combined specimen jars, missing ICD-10 links, and a single Medicare prostate biopsy rule that most coders learn about only after the denial, these are the real problems.
This guide covers everything accurately and practically. Our AAPC-certified billing team at HelloMDs has built this around what pathologists, coders, and lab managers actually face in claims work.
CPT code 88305 is a Level IV surgical pathology code. It covers two things performed by a pathologist on a single tissue specimen: a gross examination (visual inspection) and a microscopic examination (analysis under a microscope to identify disease).
The AMA’s official description: “Level IV; Surgical pathology, gross and microscopic examination.”
The gross exam means the pathologist inspects the tissue visually, measuring it, noting shape, color, and any visible abnormality. The microscopic exam means they slice thin sections, stain them, and study them under a microscope to confirm or rule out disease.
Did You Know?
One common misconception is that 88305 includes immunohistochemistry (IHC) staining and molecular testing. It does not. Those services carry their own separate CPT codes. Billing IHC under 88305 is a compliance violation and a direct audit trigger.
Not every tissue sample qualifies. CPT guidelines define specific specimen types for Level IV, including:
Does not qualify: Pap smears, urine cytology, body fluids, blood specimens, or frozen sections (which use separate pathology consultation codes).
The Jar Rule That Directly Affects Revenue:
88305 is billed once per separately accessioned specimen, not per slide or tissue fragment.
Each labeled container from a distinct anatomical site equals one billable unit. Three polyps from three different colon sites in three separate jars? Bill three times. All three in one jar? Bill once and lost $150 to $250 instantly.
Important:
This is a front-office training issue as much as a billing issue. Staff combining multiple biopsies into one container to “save time” is one of the most common and most preventable sources of revenue loss in pathology. A brief monthly audit of specimen submission habits can recover thousands of dollars in annual revenue.
Upcoding costs you in audits. Downcoding costs you in revenue. Choosing the right level matters.
Code | Level | What It Covers |
88305 | IV | Gross + microscopic; routine specimens without margin evaluation |
88307 | V | Requires microscopic evaluation of surgical margins |
88309 | VI | Complex specimens: total resections, organ removal, cancer staging |
Key Clinical Difference:
The documentation drives the code, not the specimen label, not the number of cassettes, and not whether the tissue was inked or sutured.
CMS issued a modest ~0.5% increase in pathology reimbursements in the 2026 Physician Fee Schedule. Current Medicare rates under the Clinical Laboratory Fee Schedule:
Billing Component | 2026 Medicare Rate |
Global (TC + Professional) | ~$70.14 |
Modifier 26 (Professional) only | ~$35.37 |
TC (Technical component) only | ~$35.04 |
Commercial payers typically pay $90 to $240+ per specimen, depending on your contract and market. Some commercial plans exceed 200% of the Medicare rate, which is why contract renegotiation matters at high specimen volumes.
Did You Know?
At 500 specimens per month, even a 10% coding error rate costs roughly $3,500-$5,000 in avoidable monthly revenue loss.
The Three Billing Scenarios
Important:
Billing globally when you only provided one component is one of the top three causes of 88305 denials. Always confirm which component your practice is responsible for before submitting.
This confuses many providers, especially in GI and dermatology settings. The answer is straightforward: The pathologist bills 88305, not the surgeon or proceduralist.
A GI physician performs a colonoscopy and takes biopsies. They bill their own procedure code (such as CPT 43239). The pathologist examines the tissue later and bills 88305 separately.
These are two distinct services by two different providers on two different claims. Payers expect this split. Mixing them triggers both denials and compliance flags.
Every 88305 claim needs a diagnosis code that explains why the biopsy was clinically necessary. A generic or vague ICD-10 is a clean denial.
Match the code to the clinical indication:
If the ICD-10 doesn’t justify the pathology, payers deny it as lacking medical necessity. This is one of the cleanest and most preventable denial categories in the entire practice.
HelloMDs Tip:
Our Medical Coding Services include ICD-10 pairing review on every pathology claim before submission, which is one of the fastest ways to reduce denial rates in lab billing.
Most denied 88305 claims are recoverable. Know why they were denied before resubmitting.
Common denial causes:
Medicare Rule You Must Know: Medicare does not accept CPT 88305 for prostate biopsies. Medicare requires HCPCS code G0416 for this service. Commercial payers and Medicaid generally accept 88305 for prostate, but cap units at 16 specimens per session.

HelloMDs Denial Management team handles this entire process, root cause identification, corrected claim preparation, and resubmission tracking, so nothing falls through the cracks.
The 2026 CMS fee schedule update introduced site-of-service differentials and an efficiency adjustment that affects how facility vs. non-facility pathology claims are valued. Staying compliant requires more than correct codes.
Keep these habits in place:
CPT code 88305 is not complicated, but the details cost real money when they are wrong. The jar-handling rule, ICD-10 matching, correct modifier use, and knowing the G0416 switch for Medicare prostate cases are the difference between clean claims and a mounting backlog of denials.
HelloMDs supports pathology labs, independent practices, and hospital-based pathologists across all 50 states with AAPC-certified coding, denial management, and full RCM solutions starting at 2.95% of monthly collections.
Follow HelloMDs on Facebook and Instagram for 2026 coding updates, denial prevention tips, and pathology billing guides.
This content is for educational purposes only and not medical, legal, or billing advice. Always verify CPT, ICD-10, and payer rules with official sources and insurers before submitting claims. AI-generated graphics are used for educational illustration only.
It is a Level IV surgical pathology code covering gross and microscopic examination of a qualifying tissue specimen, billed once per separately accessioned specimen.
It is a Level IV surgical pathology code covering gross and microscopic examination of a qualifying tissue specimen, billed once per separately accessioned specimen.
No. IHC and molecular testing have separate CPT codes. Billing them under 88305 is a compliance error.
Yes, once per separately accessioned specimen. Medicare and most payers cap daily units at 8-10 without additional documentation.
Medicare requires HCPCS G0416 for prostate biopsies. CPT 88305 is automatically denied for this service under Medicare.
If the pathologist evaluated the margins of the margin specimen and documented it, use 88307. If no margin evaluation was performed or documented, use 88305.
The pathologist bills 88305. The surgeon bills their own separate procedure code for collecting the specimen.